Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001144204-12-069870
Filing Date
2012-12-27
Accepted
2012-12-27 17:03:07
Documents
4

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 v330721_f-1a.htm F-1/A 137204
2 OPINION v330721_ex5-1.htm EX-5.1 44066
4 GRAPHIC mlogo.jpg GRAPHIC 6304
5 filename5.htm CORRESP 24530
  Complete submission text file 0001144204-12-069870.txt   215652
Mailing Address C/O MARK COHEN, CHAIRMAN, PEARL COHEN 1500 BROADWAY, 12TH FLOOR NEW YORK NY 10036
Business Address 53 DAVIES STREET LONDON X0 W1K 5JH 646-878-0804
Morria Biopharmaceuticals PLC (Filer) CIK: 0001541157 (see all company filings)

EIN.: 981034922 | State of Incorp.: X0
Type: F-1/A | Act: 33 | File No.: 333-185247 | Film No.: 121287874
SIC: 2834 Pharmaceutical Preparations